{
    "2020-03-03": [
        [
            {
                "time": "",
                "original_text": "【民生医药|周报】外包行业3/9：持续推荐CXO板块具备α属性的公司",
                "features": {
                    "keywords": [
                        "民生医药",
                        "外包行业",
                        "CXO板块",
                        "α属性"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国内医药CRO行业高速发展，具备技术优势企业或迎更大红利",
                "features": {
                    "keywords": [
                        "国内医药",
                        "CRO行业",
                        "高速发展",
                        "技术优势",
                        "红利"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药-马帅】从商业模式深度剖析药明康德：坚守高水平CRO服务，新药研发产业链航母再起航",
                "features": {
                    "keywords": [
                        "药明康德",
                        "商业模式",
                        "CRO服务",
                        "新药研发",
                        "产业链"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}